Design of new cGMP plasmid DNA manufacturing facility. New state of the art laboratories and manufacturing spaces allowing maximum flexibility.
Rendering Credit: FPBA & CRB
New 140,000-square-foot manufacturing facility will support viral and gene therapy production at the 1000-liter scale using its proprietary single-use equipment. The expansion is a continued investment in viral and gene therapies from clinical to commercial scale for MilliporeSigma. The construction consists of 11 new viral vector manufacturing labs, warehouse, offices, equipment mezzanine and utility yard.